Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Republic of Singapore.
Asia Pac J Ophthalmol (Phila). 2020 May-Jun;9(3):260-268. doi: 10.1097/01.APO.0000656992.00746.48.
Polypoidal choroidal vasculopathy (PCV) is a condition characterized by multiple, recurrent, serosanguineous pigment epithelial detachments, and neurosensory retinal detachments due to abnormal aneurysmal neovascular lesions. It is generally considered as a variant of neovascular age-related macular degeneration, but there are some differences between the clinical presentation, natural history, and treatment response between patients with PCV and typical neovascular age-related macular degeneration patients. Over the past decade, new research and technological advancements have greatly improved our understanding of the PCV disease process and the management of PCV. This review aims to summarize the recent research findings to highlight the epidemiology, pathogenesis, genetics, the application of various diagnostic tools for PCV, and the available treatment options for PCV.
息肉样脉络膜血管病变(PCV)是一种以多发性、复发性浆液性出血性色素上皮脱离和神经感觉性视网膜脱离为特征的疾病,其原因是异常的动脉瘤样新生血管病变。一般认为它是新生血管性年龄相关性黄斑变性的一种变异型,但 PCV 患者与典型的新生血管性年龄相关性黄斑变性患者在临床表现、自然病程和治疗反应方面存在一些差异。在过去的十年中,新的研究和技术进步极大地提高了我们对 PCV 疾病过程和 PCV 管理的理解。本文综述了最近的研究结果,重点介绍了 PCV 的流行病学、发病机制、遗传学、各种 PCV 诊断工具的应用以及 PCV 的现有治疗选择。